Isavuconazole for the prophylaxis and treatment of invasive fungal disease: A single-center experience.

Vu, Christine A; Rana, Meenakshi M; Jacobs, Samantha E; Saunders-Hao, Patricia

Vu, Christine A; Rana, Meenakshi M; Jacobs, Samantha E; Saunders-Hao, Patricia.

Affiliation

Vu CA; Department of Pharmacy, Mount Sinai Hospital, New York, NY, USA.
Rana MM; Department of Pharmacy, Jackson Memorial Hospital, Miami, FL, USA.
Jacobs SE; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Saunders-Hao P; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Transpl Infect Dis ; 23(2): e13469, 2021 Apr.

Article in En | MEDLINE | ID: mdl-32946658

Subject(s)

Invasive Fungal Infections; Nitriles/therapeutic use; Pyridines/therapeutic use; Triazoles/therapeutic use; Antifungal Agents/therapeutic use; Humans; Invasive Fungal Infections/drug therapy; Retrospective Studies

Key words

antifungal; invasive fungal disease; isavuconazole; prophylaxis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyridines / Triazoles / Invasive Fungal Infections / Nitriles Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2021 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google